Literature DB >> 32368963

Smaller Left Ventricle Size at Noncontrast CT Is Associated with Lower Mortality in COPDGene Participants.

George R Washko1, Pietro Nardelli1, Samuel Y Ash1, Farbod N Rahaghi1, Gonzalo Vegas Sanchez-Ferrero1, Carolyn E Come1, Mark T Dransfield1, Ravi Kalhan1, MeiLan K Han1, Surya P Bhatt1, J Michael Wells1, Carrie L Pistenmaa1, Alejandro A Diaz1, James C Ross1, Stephen Rennard1, Gabriela Querejeta Roca1, Amil M Shah1, Kendra Young1, Gregory L Kinney1, John E Hokanson1, Alvar Agustí1, Raúl San José Estépar1.   

Abstract

Background Smokers with chronic obstructive pulmonary disease (COPD) have smaller left ventricles (LVs) due to reduced preload. Skeletal muscle wasting is also common in COPD, but less is known about its contribution to LV size. Purpose To explore the relationships between CT metrics of emphysema, venous vascular volume, and sarcopenia with the LV epicardial volume (LVEV) (myocardium and chamber) estimated from chest CT images in participants with COPD and then to determine the clinical relevance of the LVEV in multivariable models, including sex and anthropomorphic metrics. Materials and Methods The COPDGene study (ClinicalTrials.gov identifier: NCT00608764) is an ongoing prospective longitudinal observational investigation that began in 2006. LVEV, distal pulmonary venous blood volume for vessels smaller than 5 mm2 in cross section (BV5), CT emphysema, and pectoralis muscle area were retrospectively extracted from 3318 nongated, unenhanced COPDGene CT scans. Multivariable linear and Cox regression models were used to explore the association between emphysema, venous BV5, pectoralis muscle area, and LVEV as well as the association of LVEV with health status using the St George's Respiratory Questionnaire, 6-minute walk distance, and all-cause mortality. Results The median age of the cohort was 64 years (interquartile range, 57-70 years). Of the 2423 participants, 1806 were men and 617 were African American. The median LVEV between Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1 and GOLD 4 COPD was reduced by 13.9% in women and 17.7% in men (P < .001 for both). In fully adjusted models, higher emphysema percentage (β = -4.2; 95% confidence interval [CI]: -5.0, -3.4; P < .001), venous BV5 (β = 7.0; 95% CI: 5.7, 8.2; P < .001), and pectoralis muscle area (β = 2.7; 95% CI: 1.2, 4.1; P < .001) were independently associated with reduced LVEV. Reductions in LVEV were associated with improved health status (β = 0.3; 95% CI: 0.1, 0.4) and 6-minute walk distance (β = -12.2; 95% CI: -15.2, -9.3). These effects were greater in women than in men. The effect of reduced LVEV on mortality (hazard ratio: 1.07; 95% CI: 1.05, 1.09) did not vary by sex. Conclusion In women more than men with chronic obstructive pulmonary disease, a reduction in the estimated left ventricle epicardial volume correlated with a loss of pulmonary venous vasculature, greater pectoralis muscle sarcopenia, and lower all-cause mortality. © RSNA, 2020 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2020        PMID: 32368963      PMCID: PMC7299752          DOI: 10.1148/radiol.2020191793

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  38 in total

1.  A comparison of tests for the k-sample, non-decreasing alternative.

Authors:  J M Mahrer; R C Magel
Journal:  Stat Med       Date:  1995-04-30       Impact factor: 2.373

2.  Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease.

Authors:  Surya P Bhatt; Gonzalo Vegas-Sánchez-Ferrero; Farbod N Rahaghi; Erick S MacLean; German Gonzalez-Serrano; Carolyn E Come; Gregory L Kinney; John E Hokanson; Matthew J Budoff; Michael J Cuttica; J Michael Wells; Raúl San José Estépar; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

3.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Jorge Onieva Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Chest       Date:  2017-05-12       Impact factor: 9.410

4.  Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in Smokers.

Authors:  Farbod N Rahaghi; Gonzalo Vegas-Sanchez-Ferrero; Jasleen K Minhas; Carolyn E Come; Isaac De La Bruere; James M Wells; Germán González; Surya P Bhatt; Brett E Fenster; Alejandro A Diaz; Puja Kohli; James C Ross; David A Lynch; Mark T Dransfield; Russel P Bowler; Maria J Ledesma-Carbayo; Raúl San José Estépar; George R Washko
Journal:  Acad Radiol       Date:  2017-02-15       Impact factor: 3.173

Review 5.  Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment.

Authors:  Marvin A Konstam; Daniel G Kramer; Ayan R Patel; Martin S Maron; James E Udelson
Journal:  JACC Cardiovasc Imaging       Date:  2011-01

6.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

7.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

8.  Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD.

Authors:  C Vassaux; L Torre-Bouscoulet; S Zeineldine; F Cortopassi; H Paz-Díaz; B R Celli; V M Pinto-Plata
Journal:  Eur Respir J       Date:  2008-06-11       Impact factor: 16.671

Review 9.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

10.  Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study.

Authors:  Carrie P Aaron; Eric A Hoffman; Joao A C Lima; Steven M Kawut; Alain G Bertoni; Jens Vogel-Claussen; Mohammadali Habibi; Katja Hueper; David R Jacobs; Ravi Kalhan; Erin D Michos; Wendy S Post; Martin R Prince; Benjamin M Smith; Bharath Ambale-Venkatesh; Chia-Ying Liu; Filip Zemrak; Karol E Watson; Matthew Budoff; David A Bluemke; R Graham Barr
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

View more
  2 in total

1.  Artificial Intelligence in COPD: New Venues to Study a Complex Disease.

Authors:  Raúl San José Estépar
Journal:  Barc Respir Netw Rev       Date:  2020 May-Dec

2.  Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging.

Authors:  Farbod N Rahaghi; Pietro Nardelli; Eileen Harder; Inderjit Singh; Gonzalo Vegas Sánchez-Ferrero; James C Ross; Rubén San José Estépar; Samuel Y Ash; Andetta R Hunsaker; Bradley A Maron; Jane A Leopold; Aaron B Waxman; Raúl San José Estépar; George R Washko
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.